[S02DA03, antipyrine, Antipyrine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01GA01, streptomycin, Streptomycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A02BX02, sucralfate, Tenofovir disoproxil may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Tenofovir disoproxil may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Tenofovir disoproxil may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Tenofovir disoproxil may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M01AX04, apazone, Azapropazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01BB02, mercaptopurine, The excretion of Tenofovir disoproxil can be decreased when combined with Mercaptopurine.]
[L02BA01, tamoxifen, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Tamoxifen.]
[N05CD07, temazepam, Tenofovir disoproxil may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[R03CC03, terbutaline, Tenofovir disoproxil may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Tenofovir disoproxil.]
[G03BA03, testosterone, The excretion of Tenofovir disoproxil can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The excretion of Tenofovir disoproxil can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may increase the nephrotoxic activities of Tenofovir disoproxil.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Tenofovir disoproxil may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Tenofovir disoproxil may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[G04BE06, moxisylyte, Tenofovir disoproxil may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Tenofovir disoproxil may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Tenofovir disoproxil may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[S01ED01, timolol, Tenofovir disoproxil may decrease the excretion rate of Timolol which could result in a higher serum level.]
[P01AB02, tinidazole, Tenofovir disoproxil may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Tobramycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A10BB05, tolazamide, Tenofovir disoproxil may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Tenofovir disoproxil may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N02AX02, tramadol, Tenofovir disoproxil may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[C03DB02, triamterene, Triamterene may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N05CD05, triazolam, Tenofovir disoproxil may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Tenofovir disoproxil may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Tenofovir disoproxil may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[A03AA05, trimebutine, Tenofovir disoproxil may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Tenofovir disoproxil may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Tenofovir disoproxil.]
[R03DX07, roflumilast, Tenofovir disoproxil may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Tenofovir disoproxil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Tenofovir disoproxil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Linagliptin.]
[J05AP02, telaprevir, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Telaprevir.]
[S01AA28, vancomycin, Vancomycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N03AX21, ezogabine, Tenofovir disoproxil may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be increased when it is combined with Tenofovir disoproxil.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Tenofovir disoproxil.]
[B01AC24, ticagrelor, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Verapamil.]
[N06AX09, viloxazine, Tenofovir disoproxil may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Tenofovir disoproxil.]
[L01CA02, vincristine, The serum concentration of Vincristine can be increased when it is combined with Tenofovir disoproxil.]
[B03BA01, vitamin B12, Tenofovir disoproxil may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[B01AA03, warfarin, Tenofovir disoproxil may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The excretion of Tenofovir disoproxil can be decreased when combined with Zidovudine.]
[L01EC01, vemurafenib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Tenofovir disoproxil.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Tiludronic acid.]
[B06AC02, icatibant, Tenofovir disoproxil may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Tenofovir disoproxil may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Ibandronate.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Tenofovir disoproxil may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EJ01, ruxolitinib, Tenofovir disoproxil may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Tenofovir disoproxil may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Tenofovir disoproxil may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[M01CB03, auranofin, Tenofovir disoproxil may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Tenofovir disoproxil.]
[R07AX02, ivacaftor, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ivacaftor.]
[B03XA04, peginesatide, Tenofovir disoproxil may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Tenofovir disoproxil may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Tenofovir disoproxil may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Tenofovir disoproxil.]
[J01DF01, aztreonam, Tenofovir disoproxil may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Tenofovir disoproxil.]
[M03BX01, baclofen, Tenofovir disoproxil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Tenofovir disoproxil.]
[A08AA11, lorcaserin, Tenofovir disoproxil may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Carfilzomib.]
[L02BB04, enzalutamide, Tenofovir disoproxil may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Tenofovir disoproxil.]
[L04AA31, teriflunomide, The excretion of Tenofovir disoproxil can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Regorafenib.]
[D02BA02, octinoxate, Tenofovir disoproxil may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Tenofovir disoproxil.]
[N04BD02, rasagiline, Tenofovir disoproxil may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Tenofovir disoproxil may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sildenafil.]
[V08CA11, gadofosveset, Tenofovir disoproxil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ponatinib.]
[B01AF02, apixaban, The serum concentration of Apixaban can be increased when it is combined with Tenofovir disoproxil.]
[A16AX08, teduglutide, Tenofovir disoproxil may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Lomitapide.]
[A10BH04, alogliptin, Tenofovir disoproxil may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Tenofovir disoproxil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Tenofovir disoproxil.]
[N02BA10, benorilate, Benorilate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A10BK02, canagliflozin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Canagliflozin.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Tenofovir disoproxil.]
[J02AX04, caspofungin, The excretion of Tenofovir disoproxil can be decreased when combined with Caspofungin.]
[L03AA12, ancestim, Tenofovir disoproxil may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L04AA18, everolimus, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Everolimus.]
[N04AC01, benztropine, Tenofovir disoproxil may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[L01EC02, dabrafenib, The excretion of Tenofovir disoproxil can be decreased when combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EE01, trametinib, Tenofovir disoproxil may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Tenofovir disoproxil may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Afatinib.]
[N06AX28, levomilnacipran, Tenofovir disoproxil may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Tenofovir disoproxil.]
[A10BJ03, lixisenatide, Tenofovir disoproxil may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Tenofovir disoproxil can be decreased when combined with Cholic Acid.]
[C02KX04, macitentan, Tenofovir disoproxil may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Tenofovir disoproxil may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Tenofovir disoproxil may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[J05AP05, simeprevir, The serum concentration of Simeprevir can be decreased when it is combined with Tenofovir disoproxil.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Tenofovir disoproxil.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Tenofovir disoproxil may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Tenofovir disoproxil may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Tenofovir disoproxil may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Tenofovir disoproxil may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Tenofovir disoproxil may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Tenofovir disoproxil.]
[B01AC26, vorapaxar, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vorapaxar.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Tenofovir disoproxil.]
[L01EM01, idelalisib, The serum concentration of Idelalisib can be increased when it is combined with Tenofovir disoproxil.]
[N07XX08, tafamidis, The excretion of Tenofovir disoproxil can be decreased when combined with Tafamidis.]
[V08AA01, diatrizoic acid, Tenofovir disoproxil may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Tenofovir disoproxil may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[N05CM19, suvorexant, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Eliglustat.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Tenofovir disoproxil.]
[S03AA06, gentamicin, Gentamicin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be increased when it is combined with Tenofovir disoproxil.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Tenofovir disoproxil.]
[L01EF01, palbociclib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Palbociclib.]
[L01EX08, lenvatinib, The excretion of Tenofovir disoproxil can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Tenofovir disoproxil.]
[J05AP07, daclatasvir, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, Tenofovir disoproxil may decrease the excretion rate of Acetaminophen which could result in a higher serum level.]
[L01DC01, bleomycin, Tenofovir disoproxil may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Adefovir dipivoxil.]
[J05AP06, asunaprevir, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Asunaprevir.]
[A04AD14, rolapitant, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Flibanserin.]
[M02AA25, aceclofenac, Aceclofenac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M01AB11, acemetacin, Acemetacin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The excretion of Tenofovir disoproxil can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Tenofovir disoproxil may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Tenofovir disoproxil.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Tenofovir disoproxil.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Tenofovir disoproxil.]
[L01XG03, ixazomib, Tenofovir disoproxil may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Tenofovir disoproxil.]
[M04AB05, lesinurad, Tenofovir disoproxil may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The serum concentration of Elbasvir can be increased when it is combined with Tenofovir disoproxil.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be increased when it is combined with Tenofovir disoproxil.]
[M01AE16, alminoprofen, Alminoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N03AX23, brivaracetam, Tenofovir disoproxil may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Venetoclax.]
[N05BA08, bromazepam, Tenofovir disoproxil may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Tenofovir disoproxil may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, Bumetanide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N01BB01, bupivacaine, Tenofovir disoproxil may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N05BE01, buspirone, Tenofovir disoproxil may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Arsenic trioxide.]
[M02AA03, clofezone, Tenofovir disoproxil may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A06AH05, naldemedine, Tenofovir disoproxil may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Tenofovir disoproxil may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Tenofovir disoproxil may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[P01CA02, benznidazole, Tenofovir disoproxil may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The excretion of Tenofovir disoproxil can be decreased when combined with Linezolid.]
[J05AF06, abacavir, Tenofovir disoproxil may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The serum concentration of Tipranavir can be decreased when it is combined with Tenofovir disoproxil.]
[N07XX13, valbenazine, Tenofovir disoproxil may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[J01MA23, delafloxacin, Tenofovir disoproxil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Tenofovir disoproxil.]
[L01BC06, capecitabine, Tenofovir disoproxil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The excretion of Tenofovir disoproxil can be decreased when combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Tenofovir disoproxil.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Tenofovir disoproxil.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Tenofovir disoproxil.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Tenofovir disoproxil.]
[J01DC10, cefprozil, Cefprozil may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Tenofovir disoproxil may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J05AX18, letermovir, The excretion of Tenofovir disoproxil can be decreased when combined with Letermovir.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Tenofovir disoproxil may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Tenofovir disoproxil can be decreased when combined with Captopril.]
[L02BB05, apalutamide, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Carbamazepine.]
[J01CA03, carbenicillin, The excretion of Tenofovir disoproxil can be decreased when combined with Carbenicillin.]
[C07AG02, carvedilol, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Carvedilol.]
[B02BX08, avatrombopag, The excretion of Tenofovir disoproxil can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, Tenofovir disoproxil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD10, cefetamet, Cefetamet may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD09, cefodizime, Cefodizime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC11, ceforanide, Ceforanide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD13, cefpodoxime, Cefpodoxime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Tenofovir disoproxil.]
[J01DD14, ceftibuten, Ceftibuten may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01GB14, plazomicin, Plazomicin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[H01CC03, elagolix, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Elagolix.]
[A16AX14, migalastat, Tenofovir disoproxil may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Tenofovir disoproxil can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Tenofovir disoproxil.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be increased when it is combined with Tenofovir disoproxil.]
[L01EB07, dacomitinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Dacomitinib.]
[J01AA14, sarecycline, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Tenofovir disoproxil.]
[S01GX12, cetirizine, Tenofovir disoproxil may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Tenofovir disoproxil may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N07XX15, inotersen, Inotersen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Tenofovir disoproxil.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Tenofovir disoproxil.]
[L01AD01, carmustine, Tenofovir disoproxil may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Tenofovir disoproxil.]
[L01EX13, gilteritinib, The serum concentration of Gilteritinib can be increased when it is combined with Tenofovir disoproxil.]
[L01XJ03, glasdegib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Glasdegib.]
[A06AX05, prucalopride, Tenofovir disoproxil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Tenofovir disoproxil may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[J01FA09, clarithromycin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Clarithromycin.]
[N06BA14, solriamfetol, Tenofovir disoproxil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The serum concentration of Clobazam can be increased when it is combined with Tenofovir disoproxil.]
[J01DC04, cefaclor, Cefaclor may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB05, cefadroxil, Cefadroxil may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC03, cefamandole, Cefamandole may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB07, cefatrizine, Cefatrizine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB04, cefazolin, Cefazolin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Tenofovir disoproxil.]
[J01DC09, cefmetazole, Cefmetazole may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC06, cefonicid, Cefonicid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD12, cefoperazone, Cefoperazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD01, cefotaxime, Cefotaxime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC05, cefotetan, Cefotetan may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC07, cefotiam, Cefotiam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC01, cefoxitin, Cefoxitin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD03, cefsulodin, Cefsulodin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD02, ceftazidime, Ceftazidime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD04, ceftriaxone, Ceftriaxone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01AA27, cefuroxime, Cefuroxime may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EJ02, fedratinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Pitolisant.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Tenofovir disoproxil.]
[N04CX01, istradefylline, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Daptomycin.]
[J01DB01, cephalexin, Cephalexin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB02, cephaloridine, Cefaloridine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB03, cephalothin, Cefalotin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB08, cephapirin, Cefapirin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DB09, cephradine, Cefradine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Tenofovir disoproxil.]
[N02CC08, lasmiditan, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Lasmiditan.]
[A16AX16, givosiran, Givosiran may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M09AX08, golodirsen, Tenofovir disoproxil may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Tenofovir disoproxil.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Tenofovir disoproxil.]
[S01XA12, dexpanthenol, Tenofovir disoproxil may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Tenofovir disoproxil.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be increased when it is combined with Tenofovir disoproxil.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Tenofovir disoproxil.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Tenofovir disoproxil.]
[R02AA03, dichlorobenzyl alcohol, Tenofovir disoproxil may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Tenofovir disoproxil may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C08CA16, clevidipine, Tenofovir disoproxil may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[C01BD07, dronedarone, The excretion of Tenofovir disoproxil can be decreased when combined with Dronedarone.]
[S03AA08, chloramphenicol, The excretion of Tenofovir disoproxil can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Tenofovir disoproxil which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Capmatinib.]
[M01AC04, droxicam, Droxicam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01EX19, ripretinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ripretinib.]
[V08CA05, mangafodipir, Tenofovir disoproxil may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Tenofovir disoproxil.]
[P01BA01, chloroquine, Tenofovir disoproxil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Tenofovir disoproxil may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.]
[A10BB02, chlorpropamide, Tenofovir disoproxil may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Tenofovir disoproxil may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N02BA03, choline salicylate, Tenofovir disoproxil may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M02AA06, etofenamate, Etofenamate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Tenofovir disoproxil.]
[A16AX20, lonafarnib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Tenofovir disoproxil.]
[M01AX25, chondroitin sulfates, Tenofovir disoproxil may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Tenofovir disoproxil can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Voclosporin.]
[L01EX21, tepotinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Tepotinib.]
[L01EX25, umbralisib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Tenofovir disoproxil.]
[M01AE05, fenbufen, Fenbufen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C01CA19, fenoldopam, Tenofovir disoproxil may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Tenofovir disoproxil may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S01JA01, fluorescein, The excretion of Tenofovir disoproxil can be decreased when combined with Fluorescein.]
[N02BG07, flupirtine, Tenofovir disoproxil may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Tenofovir disoproxil.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Tenofovir disoproxil.]
[A02BA01, cimetidine, The excretion of Tenofovir disoproxil can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Tenofovir disoproxil may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[J01MB06, cinoxacin, The excretion of Tenofovir disoproxil can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, Tenofovir disoproxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, Cisplatin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The excretion of Tenofovir disoproxil can be decreased when combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Tenofovir disoproxil may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Tenofovir disoproxil may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Tenofovir disoproxil.]
[V09AX06, florbetaben f-18, Tenofovir disoproxil may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L01EA06, asciminib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Clofazimine.]
[B06AX04, mitapivat, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Mitapivat.]
[N01BB10, levobupivacaine, Tenofovir disoproxil may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Tenofovir disoproxil.]
[N06AA04, clomipramine, Tenofovir disoproxil may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Tenofovir disoproxil may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Tenofovir disoproxil may decrease the excretion rate of Oseltamivir which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Tenofovir disoproxil may decrease the excretion rate of Clozapine which could result in a higher serum level.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Tenofovir disoproxil.]
[A10BK06, sotagliflozin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sotagliflozin.]
[J01GB12, arbekacin, Arbekacin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M01AX13, proquazone, Proquazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[R05DA04, codeine, The excretion of Tenofovir disoproxil can be decreased when combined with Codeine.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Tenofovir disoproxil.]
[J01XB01, colistin, Colistin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DE02, cefpirome, Cefpirome may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A04AA03, tropisetron, Tenofovir disoproxil may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Tenofovir disoproxil may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[B01AC10, indobufen, Indobufen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J05AB14, valganciclovir, Tenofovir disoproxil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Tenofovir disoproxil may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Tenofovir disoproxil may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Tenofovir disoproxil may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Tenofovir disoproxil may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Tenofovir disoproxil may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N02CC05, almotriptan, Tenofovir disoproxil may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J02AC02, itraconazole, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N05BA10, ketazolam, Tenofovir disoproxil may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J02AC04, posaconazole, The serum concentration of Posaconazole can be increased when it is combined with Tenofovir disoproxil.]
[A02BC05, esomeprazole, The excretion of Tenofovir disoproxil can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, Tenofovir disoproxil may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Tenofovir disoproxil may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M02AA31, loxoprofen, Loxoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DC08, loracarbef, Loracarbef may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C09AA03, lisinopril, Tenofovir disoproxil may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Tenofovir disoproxil may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[J01DH02, meropenem, Tenofovir disoproxil may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Tenofovir disoproxil may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA08, fluocinolone acetonide, Tenofovir disoproxil may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01XA18, cyclosporine, Cyclosporine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C10AA07, rosuvastatin, The excretion of Tenofovir disoproxil can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M01AX22, morniflumate, Morniflumate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03XA02, conivaptan, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Conivaptan.]
[G04BE09, vardenafil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vardenafil.]
[M01AH05, etoricoxib, Etoricoxib may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01AX04, dacarbazine, Tenofovir disoproxil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Tenofovir disoproxil.]
[M01AX01, nabumetone, Nabumetone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N07BB05, nalmefene, Tenofovir disoproxil may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Tenofovir disoproxil may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Tenofovir disoproxil may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Tenofovir disoproxil may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Tenofovir disoproxil may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[B01AX05, fondaparinux, Tenofovir disoproxil may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AA01, desipramine, Tenofovir disoproxil may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Tenofovir disoproxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[J01DH03, ertapenem, Tenofovir disoproxil may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N03AF02, oxcarbazepine, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Oxcarbazepine.]
[N06BA02, dextroamphetamine, Tenofovir disoproxil may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Tenofovir disoproxil may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Tenofovir disoproxil may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Tenofovir disoproxil may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R05DA08, pholcodine, Tenofovir disoproxil may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Clodronic acid.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Tenofovir disoproxil is combined with Foscarnet.]
[A03AA07, dicyclomine, Tenofovir disoproxil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, The serum concentration of Didanosine can be increased when it is combined with Tenofovir disoproxil.]
[L01DC04, ixabepilone, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ixabepilone.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Tenofovir disoproxil may decrease the excretion rate of Isradipine which could result in a higher serum level.]
[D07XC04, diflucortolone, Tenofovir disoproxil may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Tenofovir disoproxil.]
[C01AA05, digoxin, Tenofovir disoproxil may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Tenofovir disoproxil may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Tenofovir disoproxil may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The serum concentration of Atazanavir can be decreased when it is combined with Tenofovir disoproxil.]
[H03BC01, potassium perchlorate, Tenofovir disoproxil may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Tenofovir disoproxil may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[V03AB09, dimercaprol, Tenofovir disoproxil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Tenofovir disoproxil may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[M01AB14, proglumetacin, Proglumetacin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[G02AD02, dinoprostone, The excretion of Tenofovir disoproxil can be decreased when combined with Dinoprostone.]
[C05CA03, diosmin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Diosmin.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Tenofovir disoproxil.]
[S01AX06, resorcinol, Tenofovir disoproxil may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Tenofovir disoproxil may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[S02AA12, rifamycin SV, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Rifamycin.]
[R06AE09, levocetirizine, Tenofovir disoproxil may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Tenofovir disoproxil may decrease the excretion rate of Ropivacaine which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Tenofovir disoproxil.]
[G04BE08, tadalafil, Tenofovir disoproxil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Tenofovir disoproxil.]
[C01EB18, ranolazine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[H05BA01, salmon calcitonin, Tenofovir disoproxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Tenofovir disoproxil may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Tenofovir disoproxil may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Tenofovir disoproxil may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, Tenofovir disoproxil may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[A08AA10, sibutramine, Tenofovir disoproxil may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Simvastatin.]
[A12CA02, sodium sulfate, Tenofovir disoproxil may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Tenofovir disoproxil may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Tenofovir disoproxil may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Tenofovir disoproxil may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Tenofovir disoproxil.]
[J01CG02, tazobactam, The excretion of Tenofovir disoproxil can be decreased when combined with Tazobactam.]
[L01AX03, temozolomide, Tenofovir disoproxil may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C09AA02, enalapril, The excretion of Tenofovir disoproxil can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, Tolfenamic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AG03, toloxatone, Tenofovir disoproxil may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Tenofovir disoproxil may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, Tenofovir disoproxil may decrease the excretion rate of Topiramate which could result in a higher serum level.]
[L02BA02, toremifene, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Toremifene.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX16, venlafaxine, Tenofovir disoproxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M01AB04, zomepirac, Zomepirac may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N03AX15, zonisamide, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Zonisamide.]
[L01XA02, carboplatin, Carboplatin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C02AC02, guanfacine, Tenofovir disoproxil may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[L03AX05, pidotimod, Tenofovir disoproxil may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Erythromycin.]
[N05CD04, estazolam, Tenofovir disoproxil may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The excretion of Tenofovir disoproxil can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, Tenofovir disoproxil may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tenofovir disoproxil can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Tenofovir disoproxil may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[V08CA03, gadodiamide, Tenofovir disoproxil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01BD05, ibutilide, Tenofovir disoproxil may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N01AX07, etomidate, Tenofovir disoproxil may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Tenofovir disoproxil.]
[L04AD02, tacrolimus, Tacrolimus may increase the nephrotoxic activities of Tenofovir disoproxil.]
[P01AX07, trimetrexate, Tenofovir disoproxil may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Tenofovir disoproxil may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Tenofovir disoproxil may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.]
[L02AE02, leuprolide, Tenofovir disoproxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Tenofovir disoproxil can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Tenofovir disoproxil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Tenofovir disoproxil may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Tenofovir disoproxil may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Tenofovir disoproxil can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Tenofovir disoproxil may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N02AB03, fentanyl, Tenofovir disoproxil may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Tenofovir disoproxil may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Tenofovir disoproxil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07AX03, cevimeline, Tenofovir disoproxil may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Tenofovir disoproxil may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J02AC01, fluconazole, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Fluconazole.]
[J02AX01, flucytosine, Tenofovir disoproxil may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Tenofovir disoproxil may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[L01BC09, floxuridine, Tenofovir disoproxil may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N05CD01, flurazepam, Tenofovir disoproxil may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L02BB01, flutamide, Tenofovir disoproxil may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Tenofovir disoproxil may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Tenofovir disoproxil may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01BC03, tegafur, Tenofovir disoproxil may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[J05AE10, darunavir, The serum concentration of Darunavir can be increased when it is combined with Tenofovir disoproxil.]
[C03CA01, furosemide, Furosemide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N05CF04, eszopiclone, Tenofovir disoproxil may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[S01AD09, ganciclovir, The excretion of Tenofovir disoproxil can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The excretion of Tenofovir disoproxil can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Tenofovir disoproxil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Tenofovir disoproxil.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Tenofovir disoproxil.]
[L01EH01, lapatinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The excretion of Tenofovir disoproxil can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Tenofovir disoproxil may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Tenofovir disoproxil may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[L01EX02, sorafenib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sorafenib.]
[M01CB04, aurothioglucose, Tenofovir disoproxil may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Tenofovir disoproxil may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Tenofovir disoproxil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Tenofovir disoproxil may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Tenofovir disoproxil may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, Tenofovir disoproxil may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N05AH04, quetiapine, Tenofovir disoproxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Tenofovir disoproxil may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Tenofovir disoproxil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The excretion of Tenofovir disoproxil can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, Tenofovir disoproxil may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Tenofovir disoproxil.]
[C01CE02, milrinone, Tenofovir disoproxil may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[M02AA26, nimesulide, Nimesulide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C09AA04, perindopril, Tenofovir disoproxil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Tenofovir disoproxil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Tenofovir disoproxil may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Tenofovir disoproxil may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Tenofovir disoproxil may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Tenofovir disoproxil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Risedronic acid.]
[R02AX02, ibuprofen, Ibuprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[B05XA08, sodium acetate, Tenofovir disoproxil may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Tenofovir disoproxil may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Tenofovir disoproxil.]
[R01AD07, tixocortol, Tenofovir disoproxil may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Tenofovir disoproxil.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A11HA07, inositol, Tenofovir disoproxil may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Tenofovir disoproxil may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Tenofovir disoproxil may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Tenofovir disoproxil.]
[N05BA12, alprazolam, Tenofovir disoproxil may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Tenofovir disoproxil may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Tenofovir disoproxil may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[G04BE01, alprostadil, The excretion of Tenofovir disoproxil can be decreased when combined with Alprostadil.]
[J04AC01, isoniazid, Tenofovir disoproxil may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Tenofovir disoproxil may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Tenofovir disoproxil may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Kanamycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N01AX03, ketamine, Tenofovir disoproxil may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Tenofovir disoproxil may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ketoconazole.]
[M02AA10, ketoprofen, Ketoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01MB02, nalidixic acid, The excretion of Tenofovir disoproxil can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C07AG01, labetalol, Tenofovir disoproxil may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Tenofovir disoproxil may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Tenofovir disoproxil may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01AA21, amikacin, Amikacin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, The serum concentration of Loperamide can be increased when it is combined with Tenofovir disoproxil.]
[N05BA06, lorazepam, Tenofovir disoproxil may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[N05AH01, loxapine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Loxapine.]
[L01EG01, temsirolimus, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Tenofovir disoproxil may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Tenofovir disoproxil may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Tenofovir disoproxil may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Tenofovir disoproxil.]
[N06AA21, maprotiline, Tenofovir disoproxil may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Tenofovir disoproxil may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[P01BC02, mefloquine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The excretion of Tenofovir disoproxil can be decreased when combined with Melatonin.]
[N06DX01, memantine, Tenofovir disoproxil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Tenofovir disoproxil may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N01BB03, mepivacaine, Tenofovir disoproxil may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Tenofovir disoproxil may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Paliperidone.]
[A10BA02, metformin, Tenofovir disoproxil may decrease the excretion rate of Metformin which could result in a higher serum level.]
[N07BC02, methadone, Tenofovir disoproxil may decrease the excretion rate of Methadone which could result in a higher serum level.]
[N06BA03, methamphetamine, Tenofovir disoproxil may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Tenofovir disoproxil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Tenofovir disoproxil may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Tenofovir disoproxil may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may increase the nephrotoxic activities of Tenofovir disoproxil.]
[D05BA02, methoxsalen, Tenofovir disoproxil may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Tenofovir disoproxil may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Methylene blue.]
[G03EK01, methyltestosterone, The excretion of Tenofovir disoproxil can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, Tenofovir disoproxil may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Tenofovir disoproxil may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[V04CD01, metyrapone, Tenofovir disoproxil may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N05CD08, midazolam, Tenofovir disoproxil may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[G03XB01, mifepristone, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Mifepristone.]
[J05AH01, zanamivir, Tenofovir disoproxil may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, The excretion of Tenofovir disoproxil can be decreased when combined with Minocycline.]
[L03AC01, aldesleukin, Tenofovir disoproxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.]
[C01BD01, amiodarone, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, Tenofovir disoproxil may decrease the excretion rate of Amitriptyline which could result in a higher serum level.]
[N02AA01, morphine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Morphine.]
[A04AA05, palonosetron, Tenofovir disoproxil may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L04AB05, certolizumab pegol, Tenofovir disoproxil may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Tenofovir disoproxil may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Tenofovir disoproxil.]
[L04AA06, mycophenolic acid, Tenofovir disoproxil may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[G04CA04, silodosin, The serum concentration of Silodosin can be increased when it is combined with Tenofovir disoproxil.]
[N03AB05, fosphenytoin, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Fosphenytoin.]
[C07AA12, nadolol, Tenofovir disoproxil may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Tenofovir disoproxil may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The excretion of Tenofovir disoproxil can be decreased when combined with Nafcillin.]
[V03AB15, naloxone, Tenofovir disoproxil may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Tenofovir disoproxil may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AX21, duloxetine, Tenofovir disoproxil may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Tenofovir disoproxil may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Tenofovir disoproxil is combined with Neomycin.]
[B01AC17, tirofiban, Tenofovir disoproxil may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01AA19, ampicillin, Tenofovir disoproxil may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Tenofovir disoproxil may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Netilmicin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AX23, desvenlafaxine, Tenofovir disoproxil may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C01CE01, inamrinone, Tenofovir disoproxil may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C08CA05, nifedipine, Tenofovir disoproxil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C08CA07, nisoldipine, Tenofovir disoproxil may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Tenofovir disoproxil may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Tenofovir disoproxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Tenofovir disoproxil may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Tenofovir disoproxil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Tenofovir disoproxil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S01AE02, norfloxacin, The excretion of Tenofovir disoproxil can be decreased when combined with Norfloxacin.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Tenofovir disoproxil.]
[A16AX07, sapropterin, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sapropterin.]
[S02AA16, ofloxacin, The excretion of Tenofovir disoproxil can be decreased when combined with Ofloxacin.]
[N02AA02, opium, Tenofovir disoproxil may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tenofovir disoproxil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Tenofovir disoproxil can be decreased when combined with Ouabain.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Zoledronic acid.]
[J01CF04, oxacillin, Tenofovir disoproxil may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Tenofovir disoproxil may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01AA04, oxytetracycline, The excretion of Tenofovir disoproxil can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Tenofovir disoproxil can be decreased when combined with Aminohippuric acid.]
[J04AB30, capreomycin, Capreomycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A07AA06, paromomycin, Paromomycin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[G04BD11, fesoterodine, Tenofovir disoproxil may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Tenofovir disoproxil may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[S01AA14, penicillin G, The excretion of Tenofovir disoproxil can be decreased when combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, Tenofovir disoproxil may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Tenofovir disoproxil may decrease the excretion rate of Pentobarbital which could result in a higher serum level.]
[L01XX08, pentostatin, Tenofovir disoproxil may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Tenofovir disoproxil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BE03, phenacetin, The excretion of Tenofovir disoproxil can be decreased when combined with Phenacetin.]
[G04BX06, phenazopyridine, Phenazopyridine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AF03, phenelzine, Tenofovir disoproxil may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[N03AA02, phenobarbital, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Phenobarbital.]
[V03AB36, phentolamine, Tenofovir disoproxil may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N03AB02, phenytoin, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Phenytoin.]
[S01AE05, levofloxacin, Tenofovir disoproxil may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Tenofovir disoproxil may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may increase the nephrotoxic activities of Tenofovir disoproxil.]
[C08CX01, mibefradil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Mibefradil.]
[C07AA03, pindolol, Tenofovir disoproxil may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, Tenofovir disoproxil may decrease the excretion rate of Piperacillin which could result in a higher serum level.]
[J05AE01, saquinavir, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Saquinavir.]
[N06BX03, piracetam, Tenofovir disoproxil may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, Piroxicam may increase the nephrotoxic activities of Tenofovir disoproxil.]
[J01DD16, cefditoren, Cefditoren may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A10BG02, rosiglitazone, Tenofovir disoproxil may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Polymyxin B.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The risk or severity of adverse effects can be increased when Ritonavir is combined with Tenofovir disoproxil.]
[A10BH03, saxagliptin, Tenofovir disoproxil may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Tenofovir disoproxil may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[H02AB07, prednisone, Tenofovir disoproxil may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[M04AB01, probenecid, The excretion of Tenofovir disoproxil can be decreased when combined with Probenecid.]
[C01BA02, procainamide, Tenofovir disoproxil may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[C10AB05, fenofibrate, Tenofovir disoproxil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AD02, promethazine, Tenofovir disoproxil may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Propafenone.]
[A03AB05, propantheline, Tenofovir disoproxil may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Tenofovir disoproxil.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Tenofovir disoproxil.]
[C07AA05, propranolol, Tenofovir disoproxil may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[N02CC04, rizatriptan, Tenofovir disoproxil may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Tenofovir disoproxil may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Tenofovir disoproxil may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Tenofovir disoproxil may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Tenofovir disoproxil may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Tenofovir disoproxil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, Tenofovir disoproxil may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA02, reserpine, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Reserpine.]
[J05AP01, ribavirin, Tenofovir disoproxil may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[S01XA26, riboflavin, The excretion of Tenofovir disoproxil can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The excretion of Tenofovir disoproxil can be decreased when combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A07EC01, sulfasalazine, Sulfasalazine may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01BC08, salicylic acid, Salicylic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N05CA06, secobarbital, Tenofovir disoproxil may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[J01GB08, sisomicin, Sisomicin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[A12CD01, sodium fluoride, Tenofovir disoproxil may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Tenofovir disoproxil may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Tenofovir disoproxil.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CH02, indigo carmine, Tenofovir disoproxil may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Tenofovir disoproxil may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N03AG01, valproic acid, The excretion of Tenofovir disoproxil can be decreased when combined with Valproic acid.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Etidronic acid.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Alendronic acid.]
[C01DA14, isosorbide mononitrate, Tenofovir disoproxil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[H02CA04, levoketoconazole, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Levoketoconazole.]
[D10AX03, azelaic acid, Tenofovir disoproxil may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
